119 related articles for article (PubMed ID: 2199589)
21. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
22. [Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Zhiliaev EV; Urzhumova TV; Glazunov AV; Sorokoletov SM; Dzhanashiia PKh
Ter Arkh; 2000; 72(8):20-3. PubMed ID: 11019420
[TBL] [Abstract][Full Text] [Related]
23. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
[TBL] [Abstract][Full Text] [Related]
24. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Majer M; Swiatkowski M
Int J Cardiol; 2008 Jul; 127(2):233-9. PubMed ID: 17689732
[TBL] [Abstract][Full Text] [Related]
25. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
26. Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
Finimundi HC; Caramori PA; Parker JD
J Cardiovasc Pharmacol; 2007 May; 49(5):275-9. PubMed ID: 17513945
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study].
Passeron J
Presse Med; 1986 Oct; 15(35):1775-8. PubMed ID: 2947149
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of diltiazem in elderly patients with stable effort angina].
Acanfora D; De Caprio L; Obrizzo R; Longo F; Lirato C; Vigorito C; Giordano A; Odierna L; Cicatiello AM; Rengo F
G Ital Cardiol; 1989 Nov; 19(11):1007-14. PubMed ID: 2695381
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the therapeutic efficacy of vastarel 20 mg (trimetazidine) in cochleovestibular syndromes. A double-blind study versus placebo].
Wayoff M
Ann Otolaryngol Chir Cervicofac; 1984; 101(7):565-9. PubMed ID: 6391338
[TBL] [Abstract][Full Text] [Related]
30. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
McClellan KJ; Plosker GL
Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
[TBL] [Abstract][Full Text] [Related]
31. [Trimetazidine in pectoris patients older than 65 years with stable angina].
Syrkin AL; Lepakhin VK; Fitilev SB; Ivanova EV; Titarova IuIu; Levin AM
Kardiologiia; 2002; 42(6):24-31. PubMed ID: 12494126
[TBL] [Abstract][Full Text] [Related]
32. Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
[TBL] [Abstract][Full Text] [Related]
34. Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine.
Manchanda SC
Int J Cardiol; 2003 Mar; 88(1):83-9. PubMed ID: 12659989
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
[TBL] [Abstract][Full Text] [Related]
36. WITHDRAWN: Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003614. PubMed ID: 28319269
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
[TBL] [Abstract][Full Text] [Related]
38. [Trimetazidine addition to antianginal therapy: effects on efficacy and quality of life in patients with stable angina treated outpatiently].
Ter Arkh; 2012; 84(4):38-41. PubMed ID: 22774489
[TBL] [Abstract][Full Text] [Related]
39. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.
Detry JM; Sellier P; Pennaforte S; Cokkinos D; Dargie H; Mathes P
Br J Clin Pharmacol; 1994 Mar; 37(3):279-88. PubMed ID: 8198938
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Marzilli M; Klein WW
Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
